Literature DB >> 144345

Fibrinolytic activity of in vitro cultivated human bladder cell lines.

H Hisazumi, L Andersson, V P Collins.   

Abstract

Three human bladder carcinoma cell lines, T 24, RT 4, and MANO, a human bladder nonmalignant epithelial cell line, HCV-29, and a human lung fibroblast line, 460 H1, were investigated for their ability to induce fibrinolytic, urokinase and plasmin inhibitory activities in cell culture, using serum-free medium, for up to 36 h. Generally, the non-malignant cell line and the fibroblast line had a greater ability to produce urokinase inhibitor than did the malignant cell lines. The amount produced varied greatly between cells and over the study period. A low concentration of plasminogen activator, immunologically identical with urokinase, and its accumulation in culture supernate were found with RT 4 after 12 h and 24 h cultivations, whereas no plasminogen activator was detected in all other cell lines for periods up to 36 h. No plasmin, non-specific protease or plasmin inhibitory activities were detected in any of the supernates from the cell lines.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 144345     DOI: 10.1007/bf00256867

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  22 in total

1.  The histological localisation of fibrinolysin activator.

Authors:  A S TODD
Journal:  J Pathol Bacteriol       Date:  1959-07

2.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

3.  Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

Authors:  J K Christman; G Acs
Journal:  Biochim Biophys Acta       Date:  1974-03-27

4.  Urokinase inhibitor in patients with bladder cancer.

Authors:  H Hisazumi; K Naito; T Misaki; S Kosaka
Journal:  Urol Res       Date:  1974-12-20

5.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?

Authors:  C O'Toole; P Perlmann; H Wigzell; B Unsgaard; C G Zetterlund
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

7.  Inhibitors of fibrinolysis in human tissues in culture.

Authors:  M B Bernik; H C Kwaan
Journal:  Am J Physiol       Date:  1971-09

8.  A study on fibrinolysis in experimental bladder tumors.

Authors:  H Hisazumi; K Fukushima
Journal:  Urol Res       Date:  1973-12

9.  Relationship between fibrinolysis of cultured cells and malignancy.

Authors:  W E Laug; P A Jones; W F Benedict
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

10.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.

Authors:  L Ossowski; J C Unkeless; A Tobia; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

View more
  3 in total

1.  Establishment of a human renal pelvic cancer cell line producing tissue thromboplastin and plasminogen activator.

Authors:  S Naito; K Tanaka; T Kanamori; S Hisano; S Momose
Journal:  Urol Res       Date:  1982-02

2.  Immunohistochemical expressions of uPA and its receptor uPAR and their prognostic significant in urinary bladder carcinoma.

Authors:  Attalla Farag El-Kott; Abdalla Mohamed Khalil; Ayman El-Meghawry El-Kenawy
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 3.  Invasiveness of transformed bladder epithelial cells.

Authors:  J F Kieler
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.